How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
39
SPTN Quote, Financials, Valuation and Earnings
Last price:
$20.73
Seasonality move
:
6.24%
Day range:
$19.70 - $20.17
52-week range:
$17.30 - $23.00
Dividend yield:
4.34%
P/E ratio:
15.77x
P/S ratio:
0.07x
P/B ratio:
0.91x
Volume:
221.5K
Avg. volume:
283K
1-year change:
2.24%
Market cap:
$679M
Revenue:
$9.5B
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingSpartanNash has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $20.50, SpartanNash has an estimated upside of 1.94% from its current price of $20.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $20.11.
Fair Value
-
According to the consensus of 5 analysts, SpartanNash has 1.94% upside to fair value with a price target of $20.50 per share.
SPTN vs. S&P 500
-
Over the past 5 trading days, SpartanNash has overperformed the S&P 500 by 5.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
SpartanNash does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SpartanNash has grown year-over-year revenues for 1 quarter straight. In the most recent quarter SpartanNash reported revenues of $2.3B.
Earnings Growth
-
SpartanNash has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SpartanNash reported earnings per share of -$1.04.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
0.07x
EV / EBIT:
25.27x
EV / Revenue:
0.15x
PEG ratio (5yr expected):
1.75x
EV / Free cash flow:
19.21x
Price / Operating cash flow:
9.32x
Enterprise value / EBITDA:
8.86x
Gross Profit (TTM):
$1.5B
Return On Assets:
0.01%
Net Income Margin (TTM):
0%
Return On Equity:
0.04%
Return On Invested Capital:
0.02%
Operating Margin:
1.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $9.6B | $9.7B | $9.5B | $2.2B | $2.3B | |
| Gross Profit | $1.5B | $1.5B | $1.5B | $339M | $364.5M | |
| Operating Income | $69.7M | $119.3M | $131.2M | $32.5M | $29M | |
| EBITDA | $163.9M | $208.7M | $159.3M | $47.7M | -$2.4M | |
| Diluted EPS | $0.95 | $1.50 | -$0.01 | $0.30 | -$1.04 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1B | $957.2M | $1.1B | $1.1B | $1.1B | |
| Total Assets | $2.3B | $2.2B | $2.3B | $2.4B | $2.6B | |
| Current Liabilities | $689.6M | $655.8M | $705M | $659.9M | $695.2M | |
| Total Liabilities | $1.5B | $1.4B | $1.5B | $1.6B | $1.9B | |
| Total Equity | $735M | $782.9M | $766.1M | $778.2M | $743.5M | |
| Total Debt | $486.4M | $405.7M | $503.6M | $597.5M | $753.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $110.4M | $89.3M | $205.9M | -$6.4M | $82.6M | |
| Cash From Investing | -$100.9M | -$116.5M | -$247M | -$34.5M | -$136.4M | |
| Cash From Financing | $9M | $16.1M | $44.8M | $41.3M | $57.8M | |
| Free Cash Flow | $13.1M | -$31M | $73.5M | -$40.5M | $48.1M | |
SPTN
Sector
Market Cap
$679M
$259.5M
Price % of 52-Week High
87.44%
72.69%
Dividend Yield
4.34%
0%
Shareholder Yield
0.4%
3.16%
1-Year Price Total Return
2.24%
-10.07%
Beta (5-Year)
0.531
0.419
Dividend yield:
4.34%
Annualized payout:
$0.87
Payout ratio:
10003.01%
Growth streak:
13 years
Technicals
8-day SMA
Buy
Level
$19.53
200-day SMA
Buy
Level
$19.91
Bollinger Bands (100)
Buy
Level
18.34 - 20.02
Chaikin Money Flow
Buy
Level
13.4M
20-day SMA
Buy
Level
$19.79
Relative Strength Index (RSI14)
Buy
Level
54.75
ADX Line
Buy
Level
15.11
Williams %R
Neutral
Level
-32.8947
50-day SMA
Buy
Level
$19.79
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
37.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.2775)
Buy
CA Score
(Annual)
Level (0.2654)
Buy
Beneish M-Score
(Annual)
Level (-2.8713)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (91.7865)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
Stock Forecast FAQ
In the current month, SPTN has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The SPTN average analyst price target in the past 3 months is $20.50.
-
Where Will SpartanNash Stock Be In 1 Year?
According to analysts, the consensus estimate is that SpartanNash share price will rise to $20.50 per share over the next 12 months.
-
What Do Analysts Say About SpartanNash?
Analysts are divided on their view about SpartanNash share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SpartanNash is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is SpartanNash's Price Target?
The price target for SpartanNash over the next 1-year time period is forecast to be $20.50 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is SPTN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SpartanNash is a Hold. 5 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SPTN?
You can purchase shares of SpartanNash via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SpartanNash shares.
-
What Is The SpartanNash Share Price Today?
SpartanNash was last trading at $20.73 per share. This represents the most recent stock quote for SpartanNash. Yesterday, SpartanNash closed at $20.11 per share.
-
How To Buy SpartanNash Stock Online?
In order to purchase SpartanNash stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
